LifePoint Health, Inc.
LPNT
LPNT was delisted on the 15th of November, 2018.
219 hedge funds and large institutions have $2.12B invested in LifePoint Health, Inc. in 2018 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 82 increasing their positions, 75 reducing their positions, and 27 closing their positions.
11% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 27
7% more capital invested
Capital invested by funds: $1.98B → $2.12B (+$133M)
9% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 75
1% more funds holding
Funds holding: 217 → 219 (+2)
53% less call options, than puts
Call options by funds: $1.05M | Put options by funds: $2.24M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$53.3M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
+$23.9M |
| 3 |
JP Morgan Chase
New York
|
+$19.1M |
| 4 |
ECP
Elk Creek Partners
Denver,
Colorado
|
+$17.2M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$11.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$20.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$17.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$16.6M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$8.37M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
-$6.01M |
LPNT Hedge Fund Activity: Q2 2018 in Review
219 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in LifePoint Health, Inc. (LPNT) for Q2 2018, worth a combined $2.12B — up 6.7% from $1.98B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new LPNT positions and 27 closed out — a net gain of 3 holders — while 82 added to existing stakes and 75 trimmed.
The largest buyer was BlackRock, adding an estimated $53.3M. The largest seller was OrbiMed, cutting an estimated $20.2M.
- 219 institutional investors held LifePoint Health, Inc. (LPNT) as of Q2 2018, up from 217 in Q1 2018.
- Funds reported $2.12B of LifePoint Health, Inc. stock for Q2 2018, up 6.7% quarter-over-quarter.
- 30 funds opened new LifePoint Health, Inc. positions in Q2 2018 and 27 closed out, a net change of +3 holders.
- The largest LifePoint Health, Inc. buyer in Q2 2018 was BlackRock, an estimated $53.3M added.
- The largest LifePoint Health, Inc. seller in Q2 2018 was OrbiMed, an estimated $20.2M sold.
Based on aggregated 13F filings for Q2 2018.